Envestnet Asset Management’s ALPS Medical Breakthroughs ETF SBIO Stock Holding History

Envestnet Asset Management’s Portfolio SBIO Stock Details SBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-4,683	Closed	-$235K	–	3692
2021 Q1	$235K	Buy	+4,683	New	+$259K	﹤0.01%	3265
2020 Q3	–	Sell	-5,935	Closed	-$248K	–	3175
2020 Q2	$248K	Buy	+5,935	New	+$234K	﹤0.01%	2777
2019 Q1	–	Sell	-24,923	Closed	-$701K	–	3024
2018 Q4	$701K	Buy	+24,923	New	+$826K	﹤0.01%	1945
2018 Q3	–	Sell	-332	Closed	-$12K	–	2355
2018 Q2	$12K	Hold	332	–	–	﹤0.01%	2508
2018 Q1	$11K	Hold	332	–	–	﹤0.01%	2483
2017 Q4	$11K	Buy	332 +292	+730%	+$9.14K	﹤0.01%	2612
2017 Q3	$1K	Sell	40 -292	-88%	-$8.57K	﹤0.01%	2866
2017 Q2	$9K	Hold	332	–	–	﹤0.01%	2733
2017 Q1	$9K	Hold	332	–	–	﹤0.01%	2807
2016 Q4	$8K	Buy	+332	New	+$7.95K	﹤0.01%	2810

Other funds holding SBIO

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

NAM

NTV Asset Management Charleston, West Virginia $910M AUM 27.02% 1-Year Est. Return

CCP

Cardan Capital Partners Denver, Colorado $893M AUM 22.82% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Envestnet Asset Management's SBIO Position: Q2 2021 in Review

Envestnet Asset Management sold out of ALPS Medical Breakthroughs ETF (SBIO) in Q2 2021, closing a stake of 4,683 shares — an estimated $235K sold.

Envestnet Asset Management first reported a position in SBIO in Q4 2016 and held it in 10 quarters. The position peaked at $701K in Q4 2018. 66 funds tracked by Wall St. Rank hold SBIO as of Q2 2021.

Envestnet Asset Management reported no remaining ALPS Medical Breakthroughs ETF position as of Q2 2021 after selling out during the quarter.
Envestnet Asset Management sold 4,683 ALPS Medical Breakthroughs ETF shares in Q2 2021, an estimated $235K.
Envestnet Asset Management first reported a position in ALPS Medical Breakthroughs ETF in Q4 2016 and held it in 10 quarters.
Envestnet Asset Management's ALPS Medical Breakthroughs ETF position peaked at $701K in Q4 2018.
66 funds tracked by Wall St. Rank held ALPS Medical Breakthroughs ETF as of Q2 2021.

Based on Envestnet Asset Management's 13F filing for Q2 2021, filed 4 Aug 2021.